Daniel R. Pascheles, PhD, Molekule Consulting LLC, Miami, FL, USA; Claudia A. Piano, ISMPP CMPP™, CMC Connect, McCann Health Medical Communications, Radnor, PA, USA As medical affairs and medical publication professionals, it is important to understand how competitive...
Open Pharma recently released its Position Statement on Open Access, which advocates that access to pharmaceutical company-funded research should not be restricted by journal paywalls. The Position Statement points out that approximately half of all biomedical...
Challenges with authorship of industry-sponsored publications persist despite established guidelines and recommendations (International Committee of Medical Journal Editors [ICMJE] recommendations, Good Publication Practice 3 [GPP3] guidelines). While adherence to the...
Gretchen Chidester, PhD, MedThink SciCom; Jamie L. Kistler, PhD, Parexel International; Boyd Scott, PhD, Merck & Co., Inc; Keith J. Gaddie, PhD Scientific communication platforms (SCPs) were first introduced into pharmaceutical practices more than a decade ago....
ISMPP is pleased to share information about a publication on Good Practice for Conference Abstracts and Presentations (GPCAP); a publication and presentation related to Good Publication Practice 3 (GPP3) guidelines in the Asia Pacific region; and publications on open...
